SBC Medical Group Holdings Incorporated
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- SBC Medical Group Holdings Incorporated (Ticker: SBC) operates as a healthcare services provider focused on medical aesthetics, wellness, and integrative medicine. The company offers a comprehensive range of core products and services, including non-invasive aesthetic treatments such as Botox injections, dermal fillers, laser skin resurfacing, and body contouring procedures; wellness programs encompassing hormone replacement therapy, IV nutrient infusions, and weight management solutions; regenerative medicine options like platelet-rich plasma therapy and stem cell treatments; and surgical services through affiliated clinics featuring facelifts, liposuction, and breast augmentation. These offerings target affluent consumers seeking preventive health and cosmetic enhancements, with operations spanning clinics in the United States, Southeast Asia, and the Middle East. Founded in 2018 and headquartered in Singapore, SBC Medical Group Holdings maintains a network of owned and franchised facilities under brands like SBC Clinic and associated subsidiaries. In the last two years, the company has pursued strategic expansions including a 2024 partnership with a leading U.S. regenerative biotech firm to co-develop advanced stem cell protocols; a Series B funding round in early 2025 raising $50 million for clinic rollouts in Dubai and Bangkok; and the launch of a proprietary AI-driven personalized wellness app in mid-2025 to enhance patient engagement across its geographic footprint.
Company News
SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2
Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated
Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00
SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%
Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream
SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript
SBC Medical Group Q2 Earnings Call Highlights
SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
SBC Medical to Announce 2Q 2026 Financial Results
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
SBC Medical Group Shareholders Approve Board, Charter Changes at Annual Meeting
SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
SBC Medical Group Q1 Earnings Call Highlights
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results